PulseAugur
EN
LIVE 18:48:15
ENTITY ER-100

ER-100

PulseAugur coverage of ER-100 — every cluster mentioning ER-100 across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
0
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_81787 ·

    Life BioSciences begins Phase 1 trial for optic neuropathy drug

    Life BioSciences has announced a significant milestone with the first patient dosed in a Phase 1 clinical trial for ER-100, an epigenetic restoration drug candidate. This drug targets optic neuropathies, a group of diso…